In Re Bradley Pharmaceuticals, Inc. Securities Litigation

How courts have described this case

Verbatim parenthetical descriptions written by other courts when citing this decision. Ranked by citation-network relevance.

• finding that the revelation of the truth about the Company’s misrepresentations “did not take the form of a single unitary disclosure, but occurred through a series of disclosing events.”
• holding 8 The Court applies Rule 8 rather than the heightened 9(b) pleading standard in determining loss causation. See, e.g., Dura, 544 U.S. at 347; Hall, 2019 WL 7207491, at (collecting cases

Source: CourtListener parenthetical corpus (CC0).